Point72 Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.4M | Buy |
+59,341
| New | +$19.5M | 0.02% | 884 |
|
|
2025
Q2 | – | Sell |
-217,598
| Closed | -$87.5M | – | 2303 |
|
|
2025
Q1 | $94.6M | Buy |
+217,598
| New | +$87.4M | 0.22% | 109 |
|
|
2024
Q3 | – | Sell |
-242,881
| Closed | -$130M | – | 2078 |
|
|
2024
Q2 | $132M | Sell |
242,881
-60,574
| -20% | -$32M | 0.34% | 53 |
|
|
2024
Q1 | $157M | Buy |
303,455
+239,147
| +372% | +$119M | 0.38% | 45 |
|
|
2023
Q4 | $30.3M | Buy |
64,308
+62,104
| +2,818% | +$28.7M | 0.07% | 321 |
|
|
2023
Q3 | $960K | Sell |
2,204
-6,543
| -75% | -$2.97M | ﹤0.01% | 1338 |
|
|
2023
Q2 | $3.89M | Sell |
8,747
-287,021
| -97% | -$132M | 0.01% | 891 |
|
|
2023
Q1 | $136M | Buy |
295,768
+232,943
| +371% | +$111M | 0.42% | 45 |
|
|
2022
Q4 | $32.2M | Buy |
+62,825
| New | +$31.9M | 0.11% | 238 |
|
|
2022
Q2 | – | Sell |
-61,151
| Closed | -$30.3M | – | 1451 |
|
|
2022
Q1 | $30M | Buy |
61,151
+17,451
| +40% | +$7.98M | 0.12% | 228 |
|
|
2021
Q4 | $20.3M | Sell |
43,700
-104,400
| -70% | -$43.9M | 0.08% | 334 |
|
|
2021
Q3 | $55.2M | Buy |
148,100
+78,840
| +114% | +$30M | 0.24% | 92 |
|
|
2021
Q2 | $26.4M | Buy |
69,260
+34,760
| +101% | +$13.3M | 0.12% | 228 |
|
|
2021
Q1 | $12.4M | Sell |
34,500
-237,743
| -87% | -$76.5M | 0.06% | 379 |
|
|
2020
Q4 | $87.4M | Buy |
272,243
+217,943
| +401% | +$66.9M | 0.43% | 44 |
|
|
2020
Q3 | $14.6M | Buy |
+54,300
| New | +$14.6M | 0.07% | 331 |
|
|
2019
Q2 | – | Sell |
-602,597
| Closed | -$173M | – | 1386 |
|
|
2019
Q1 | $173M | Buy |
602,597
+557,470
| +1,235% | +$161M | 0.78% | 20 |
|
|
2018
Q4 | $11.9M | Sell |
45,127
-36,263
| -45% | -$9.97M | 0.06% | 373 |
|
|
2018
Q3 | $22.3M | Sell |
81,390
-220,263
| -73% | -$57.2M | 0.09% | 278 |
|
|
2018
Q2 | $71.8M | Buy |
301,653
+166,553
| +123% | +$38.6M | 0.29% | 93 |
|
|
2018
Q1 | $29.7M | Sell |
135,100
-27,600
| -17% | -$6.48M | 0.12% | 208 |
|
|
2017
Q4 | $36.6M | Buy |
+162,700
| New | +$34.7M | 0.16% | 176 |
|
|
2017
Q1 | – | Sell |
-5,000
| Closed | -$719K | – | 843 |
|
|
2016
Q4 | $719K | Sell |
5,000
-56,000
| -92% | -$7.5M | 0.01% | 618 |
|
|
2016
Q3 | $7.64M | Buy |
+61,000
| New | +$7.88M | 0.05% | 328 |
|
|
2016
Q2 | – | Sell |
-167,800
| Closed | -$23.3M | – | 760 |
|
|
2016
Q1 | $23.3M | Buy |
+167,800
| New | +$22.4M | 0.18% | 154 |
|
|
2014
Q3 | – | Sell |
-3,000
| Closed | -$323K | – | 679 |
|
|
2014
Q2 | $323K | Buy |
+3,000
| New | +$309K | ﹤0.01% | 654 |
|
Other funds holding ELV
VCM
VPM
Point72 Asset Management's ELV Position: Q1 2026 in Review
Point72 Asset Management opened a new position in Elevance Health (ELV) in Q1 2026: 59,341 shares worth $17.4M. The stake represents 0.02% of the portfolio and ranks #884 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in ELV as recently as Q1 2025.
Point72 Asset Management first reported a position in ELV in Q2 2014 and has held it in 26 quarters since. The position peaked at $173M in Q1 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Point72 Asset Management held 59,341 shares of Elevance Health worth $17.4M as of Q1 2026.
- Elevance Health was a new Point72 Asset Management position in Q1 2026.
- Elevance Health made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #884 holding.
- Point72 Asset Management first reported a position in Elevance Health in Q2 2014 and has held it in 26 quarters since.
- Point72 Asset Management's Elevance Health position peaked at $173M in Q1 2019.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.